SEC 13F Intelligence

Marshall & Sullivan Inc /Wa/ / CELG

Marshall & Sullivan Inc /Wa/’s Celgene Corp Position

Does Marshall & Sullivan Inc /Wa/ own Celgene Corp (CELG)? Not currently — the last reported position was 19.2K shares worth $2M in Q1 2019; the fund’s latest 13F (Q3 2025) no longer reports it.

Position Value
$2M
Q1 2019
Shares
19.2K
% of Portfolio
+1.33%
Quarters Held
2
position exited

Position History CELG

Reported value by quarter
Q4 ’18: $1MQ4 ’18Q1 ’19: $2MQ1 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q1 201919.2K$2M+1.33%
Q4 201819.3K$1M+1.07%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Marshall & Sullivan Inc /Wa/’s full portfolio or all institutional holders of CELG.